Medicine Experts

Chaim Hurvitz

Executive Director
foamix pharmaceuticals
Pharma Two B


Chaim Hurvitz joined Galmed’s Board in 2011. Mr. Hurvitz currently serves as the CEO of CH Health, a private venture capital firm; a position he has held since May 2011. Previously, he was a member of Teva’s senior management team, serving as the President of Teva International Group from 2002 until 2010, as President and CEO of Teva Pharmaceuticals Europe from 1992 to 1999 and as Vice President, Israeli Pharmaceutical Sales from 1999 until 2002. Additionally, from 2011 until 2014, Mr. Hurvitz served as a member of the Board of Directors of Teva Pharmaceuticals Industries Ltd. Mr. Hurvitz presently serves as a director at Aposense Ltd., a company specializing in the development of proprietary drug conjugates for approved drug therapies to enhance their effectiveness. He is a member of management for the Manufacturers Association of Israel, and head up its pharmaceutical branch. Mr. Hurvitz has been Chairperson of the Research and Development Committee since May 2014. He holds a Bachelor of Arts degree in political science and economics from Tel Aviv University, which was awarded in 1985.

Research Interest

Pharmaceutical science 

Global Experts from Israel

Global Experts in Subject